Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe

Mayall, S; Kahlon, R; Al-Dakkak, I; Shen, SW

Mayall, S (corresponding author), Pope Woodhead & Associates Ltd, Dev Consulting, St Ives, Cambs, England.; Mayall, S (corresponding author), Axian Consulting Ltd, Cambridge, England.

PHARMACEUTICAL MEDICINE, 2021; 35 (2): 123

Abstract

Background Apixaban (ELIQUIS(R)) is a direct oral anticoagulant authorised for multiple indications in the European Economic Area (EEA). Additional ri......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索